,
Whether you are using semaglutide, tirzepatide, or another provider-prescribed medication, one thing is clear: eating less can change what your body needs day to day
Additionally, various combinations of incretin-based therapies such as Cagrisema and Retatrutide have entered phase III clinical trials, with early data suggesting they may offer an even greater degree of weight reduction benefits
Most patients report similar weight loss results with compounded semaglutide compared to the brand-name versions, assuming the compounded medication is properly formulated and dosed correctly
Recommended Testing Approach There is no single schedule appropriate for everyone
In the Phase 2 obesity trial, which followed adults with obesity or overweight for 48 weeks, the average reductions in body weight were striking: To put that in perspective, at the 12 mg dose, more than eight in ten participants lost at least 15% of their starting body weight